BUMEDINST 6224.8B Tuberculosis Control Program

Question 1

What is the tuberculosis control instruction?

Answer 1

BUMEDINST 6224.8B

Question 2

What form is the Initial Tuberculosis Exposure Risk Assessment?

Answer 2

NAVMED 6224/7

Question 3

What from is the Interim Tuberculosis Exposure Risk Assessment?

Answer 3

NAVMED 6224/8

Question 4

What form is the Monthly Evaluation for Patient’s Receiving Treatment for Latent Tuberculosis Infection?

Answer 4

NAVMED 6224/9

Question 5

What is the approved tuberculin skin test material for the routine Mantoux test?

Answer 5

Tween-80 -stabilized intermediate strengthen PPD

Question 6

What form is the adult immunization record?

Answer 6

NAVMED 6230/4

Question 7

What form is the child immunization record?

Answer 7

NAVMED 6230/5

Question 8

Within how many hours must a TST be read after PPD administration?

Answer 8

48-72

Question 9

How do you record the results of a TST when there is no induration?

Answer 9

“0 mm” or “zero mm”

Question 10

What blood Assay for M. tuberculosis can be used instead of doing the TST?

Answer 10

QuntiFERON - TB Gold (QFT-G)

Question 11

What is the normal latent tuberculosis infection (LTBI) conversion rate per year in most Navy and Marine Corps settings?

Answer 11

1-2 percent

Question 12

Who must be contacted for guidance if the rate of newly identified LTBI converters is two times greater than the expected baseline conversion rate?

Answer 12

NAVENPVNTMEDU

Question 13

What is considered a positive TST in a “high risk” patient?

Answer 13

5 mm of Induration or greater

Question 14

What is considered a positive TST in “Medium risk” patients?

Answer 14

10 mm of induration or greater

Question 15

What is considered a positive TST in “Low Risk” patients?

Answer 15

15 mm of induation or greater

Question 16

What are some things that make a patient a high risk when determining TST reactions?

Answer 16

Recent close contact with active TB patients
Fibrotic or other changes on CXR
Patient’s suspected of having active TB

Question 17

What are some things that make a patient a “medium risk” when determining TST reactions?

Answer 17

Recent immigrants (within 5 years)
Mycobacteriology lab personnel
Person with clinical conditions that put them at risk

Question 18

What form is used to evaluate a patient that has a positive TST?

Answer 18

NAVMED 6224/7, Initial Tuberculosis Exposure Risk Assessment

Question 19

What medication is used to treat LTBI?

Answer 19

Isoniazid (INH)

Question 20

What is the dose of Isoniazid (INH) when treating LTBI?

Answer 20

5mg/kg (300mg max) daily for 9 months (270 daily doses)

Question 21

Within how many months must the 270 daily doses of INH be achieved when treating LTBI?

Answer 21

12 months

Question 22

What is the dose of INH when doing directly observed therapy (DOT)?

Answer 22

15mg/kg (900mg max) twice weekly x 9 months

Question 23

What form is used for monthly follow up of patients being treated with INH?

Answer 23

NAVMED 6224/9, Monthly Evaluation of Patients Receiving Therapy for LTBI

Question 24

When a command has a patient Dx with active TB, who is responsible for ensuring the contact investigation is initiated rapidly?

Answer 24

CO/OIC of individual diagnosed

Question 25

What type of mask should patients be placed in when they are suspected of having active TB?

Answer 25

Surgical mask

Question 26

What PPE should medical department personnel wear when working in rooms or spaces containing a person known or suspected of active TB?

Answer 26

particulate respirator (N95)

Question 27

How promptly must a Medical Event Report be submitted for all new cases of active TB?

Answer 27

Within 24 hours